Medication info
Cozaar-X Tablets 5/100 mg (Amlodipine, Losartan Potassium)

Cozaar-X Tablets 5/100 mg (Amlodipine, Losartan Potassium)

Prescription medicationTabletOral
Ingredient · strength
Amlodipine Besylate›6.944mg / 1 tabletLosartan Potassium›100mg / 1 tablet
Manufacturer / importer
Youngpoong Pharmaceutical Co., Ltd.
Appearance
Light pink oblong film-coated tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 201502671 · Approved 2015.04.30 · Insurance code 661904530

Summary

Main use
Essential hypertension; treatment of stage 2 hypertension
Who takes it
Adults · Children
Adult dose
The recommended dose of this medicine is 1 tablet once daily, taken with water, regardless of meals. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). It is recommended that the dose be adjusted using the individual components (amlodipine or losartan) before starting this medicine. However, if blood pressure is not controlled with monotherapy using an individual component, switching directly to this medicine may be considered as follows. - 5/50 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 50 mg monotherapy. - 5/100 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 100 mg monotherapy. Patients taking amlodipine and losartan concomitantly may switch to this medicine (a combination product with the same amounts of each active ingredient) for convenience. Before using this medicine as initial therapy in patients with stage 2 hypertension, the decision to administer it should take into account baseline blood pressure, target blood pressure, and the expected likelihood of reaching the treatment goal with combination therapy compared with monotherapy. The usual dose is 5/50 mg once daily. If blood pressure is not adequately controlled after 2 weeks of treatment, the dose may be increased to 10/50 mg once daily. ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild renal impairment (e.g., creatinine clearance 20∼50 mL/min); however, use of this medicine is not recommended in patients with moderate to severe renal impairment (e.g., creatinine clearance < 20 mL/min) or in patients undergoing dialysis. ○ Patients with reduced intravascular volume: Use of this medicine is not recommended in the small number of patients with reduced intravascular volume (e.g., patients receiving treatment with high doses of diuretics). (See Section 1. Warnings under Precautions for Use.) ○ Patients with hepatic impairment: Use of this medicine is not recommended in patients with a history of hepatic impairment who require a reduced dose of losartan (e.g., 25 mg once daily). ○ Elderly patients: In elderly patients aged 75 years or older, an initial dose of losartan of 25 mg once daily is recommended; therefore, use of this medicine as initial therapy is not recommended.
Child dose
○ Pediatric patients aged 18 years or younger: Use of this medicine is not recommended because its safety and efficacy have not been established.

Ingredients

Manufacturer
Youngpoong Pharmaceutical Co., Ltd.

Efficacy & effects

Essential hypertension; treatment of stage 2 hypertension

  • Essential hypertension
  • stage 2 hypertension
View approved original text

This medication is used in patients with essential hypertension who have difficulty controlling blood pressure with monotherapy of either amlodipine or losartan. It is also used as initial therapy in patients with stage 2 hypertension who require combination therapy to reach target blood pressure. Therefore, this medication effectively aids in the management of hypertension.

How to take

Adult dose

The recommended dose of this medicine is 1 tablet once daily, taken with water, regardless of meals. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). It is recommended that the dose be adjusted using the individual components (amlodipine or losartan) before starting this medicine. However, if blood pressure is not controlled with monotherapy using an individual component, switching directly to this medicine may be considered as follows. - 5/50 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 50 mg monotherapy. - 5/100 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 100 mg monotherapy. Patients taking amlodipine and losartan concomitantly may switch to this medicine (a combination product with the same amounts of each active ingredient) for convenience. Before using this medicine as initial therapy in patients with stage 2 hypertension, the decision to administer it should take into account baseline blood pressure, target blood pressure, and the expected likelihood of reaching the treatment goal with combination therapy compared with monotherapy. The usual dose is 5/50 mg once daily. If blood pressure is not adequately controlled after 2 weeks of treatment, the dose may be increased to 10/50 mg once daily. ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild renal impairment (e.g., creatinine clearance 20∼50 mL/min); however, use of this medicine is not recommended in patients with moderate to severe renal impairment (e.g., creatinine clearance < 20 mL/min) or in patients undergoing dialysis. ○ Patients with reduced intravascular volume: Use of this medicine is not recommended in the small number of patients with reduced intravascular volume (e.g., patients receiving treatment with high doses of diuretics). (See Section 1. Warnings under Precautions for Use.) ○ Patients with hepatic impairment: Use of this medicine is not recommended in patients with a history of hepatic impairment who require a reduced dose of losartan (e.g., 25 mg once daily). ○ Elderly patients: In elderly patients aged 75 years or older, an initial dose of losartan of 25 mg once daily is recommended; therefore, use of this medicine as initial therapy is not recommended.

Child dose

○ Pediatric patients aged 18 years or younger: Use of this medicine is not recommended because its safety and efficacy have not been established.

Precautions

This medication can cause serious harm to the fetus if taken during pregnancy, especially in the second and third trimesters, so it should be discontinued immediately upon confirmation of pregnancy. Due to its blood pressure-lowering effects, patients starting this medication may experience dizziness or symptoms of hypotension, so caution is required. Patients with known allergies to the components of this medication, severely impaired liver function, women who are pregnant or breastfeeding, and patients with severe heart valve disease should not take this medication. Patients with low blood volume or decreased kidney function, and those on strict salt restrictions should be monitored closely when using this medication. Dizziness, headaches, drowsiness, and other neurological symptoms, as well as indigestion, nausea, skin itching, palpitations, etc., may occur, and any unusual symptoms should be reported. When taken with other antihypertensives, the blood pressure-lowering effect may be enhanced, so it should be taken as directed by a physician. Taking it with grapefruit juice can increase the medication's effects, so it is advisable to avoid concurrent consumption. This medication can affect liver and kidney function, so regular tests are required to monitor status. Overdose can lead to severe hypotension or cardiac rhythm abnormalities, so prescribed dosages must be strictly followed. This medication is not recommended for children, adolescents under 18 years, or elderly patients over 75 years. For breastfeeding women, it is safer not to take this medication due to the possibility of excretion in breast milk. This medication should be kept out of reach of children, and it is best not to transfer it to another container.

Side effects

  • Dizziness
  • headache
  • drowsiness
  • cerebral infarction
  • weakness
  • chest discomfort
  • chest pain
  • early satiety
  • peripheral edema
  • pitting edema
Show 172 more
  • abdominal discomfort
  • dyspepsia
  • nausea
  • gastroesophageal reflux
  • constipation
  • pruritus
  • urticaria
  • palpitations
  • flushing
  • orthostatic hypotension
  • facial flushing
  • dyspnea
  • cough
  • conjunctival injection
  • polyuria
  • fatigue
  • edema
  • vasculitis
  • hypertonia
  • sensory loss
  • sensory abnormalities
  • peripheral neuropathy
  • syncope
  • dysgeusia
  • tremor
  • erectile dysfunction
  • gynecomastia
  • changes in bowel habits
  • dry mouth
  • gastritis
  • gingival hypertrophy
  • pancreatitis
  • vomiting
  • hyperglycemia
  • arthralgia
  • low back pain
  • muscle cramps
  • myalgia
  • leukopenia
  • thrombocytopenia
  • insomnia
  • mood changes
  • rhinitis
  • hair loss
  • increased sweating
  • purpura
  • skin discoloration
  • toxic epidermal necrolysis
  • tinnitus
  • visual disturbances
  • increased urinary frequency
  • urination disorders
  • nocturia
  • hepatitis
  • jaundice
  • elevated liver enzymes
  • pruritus
  • rash
  • angioedema
  • erythema multiforme
  • myocardial infarction
  • arrhythmia
  • abdominal discomfort
  • diarrhea
  • loose stools
  • skin flushing
  • papular rash
  • heaviness
  • warmth
  • impaired glucose tolerance
  • weakness
  • muscle cramps
  • low back pain
  • leg pain
  • congestion
  • upper respiratory infection
  • sinusitis
  • diarrhea
  • pharyngitis
  • myalgia
  • insomnia
  • bloating
  • abdominal pain
  • angioedema
  • skin desquamation
  • hemolysis
  • facial edema
  • fever
  • orthostatic effects
  • angina pectoris
  • second-degree atrioventricular block
  • cerebrovascular accident
  • hypotension
  • atrial fibrillation
  • bradycardia
  • tachycardia
  • ventricular tachycardia
  • ventricular fibrillation
  • loss of appetite
  • toothache
  • flatulence
  • gastritis
  • anemia
  • gout
  • upper limb pain
  • hip joint pain
  • joint swelling
  • knee pain
  • musculoskeletal pain
  • shoulder pain
  • muscle rigidity
  • arthritis
  • fibromyalgia
  • myasthenia
  • anxiety
  • anxiety disorder
  • ataxia
  • confusion
  • depression
  • nightmares
  • sensory reduction
  • decreased libido
  • memory impairment
  • migraine
  • hypersensitivity
  • panic disorder
  • sleep disorder
  • bronchitis
  • pharyngeal discomfort
  • epistaxis
  • respiratory congestion
  • dermatitis
  • dry skin
  • petechial hemorrhage
  • erythema
  • photophobia
  • rash
  • sweating
  • blurred vision
  • burning sensation and pain in the eyes
  • conjunctivitis
  • dysgeusia
  • tinnitus
  • visual impairment
  • urinary tract infection
  • hypotension
  • loss of consciousness
  • acute hepatitis
  • fulminant hepatitis
  • anaphylactic syndrome
  • angioedema
  • vasculitis
  • anaphylactic reaction
  • intestinal vascular edema
  • fatigue
  • thrombocytopenia
  • rhabdomyolysis
  • dysgeusia
  • dry cough
  • erythroderma
  • hyperkalemia
  • hyponatremia
  • elevated ALT
  • increased serum creatinine
  • elevated liver enzymes
  • shock symptoms
  • loss of consciousness
  • dyspnea
  • hypotension
  • tachycardia
  • reflex tachycardia
  • systemic hypotension

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or moisture, so it should be stored in a tightly sealed container. It is best to store it at room temperature, between 1°C and 30°C. This helps maintain the medication's effectiveness for a longer period.

Appearance and packaging

Appearance

Light pink oblong film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.